lividomycin has been researched along with paromomycin in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 12 (54.55) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Alborn, WE; Allen, NE; Kirst, HA; Toth, JE | 1 |
| Cedergren, R; Leclerc, F | 1 |
| Dominick, PK; Jarstfer, MB; Keppler, BR; Legassie, JD; Moon, IK | 1 |
| Avison, MB; Okazaki, A | 1 |
| Arakawa, Y; Ike, Y; Kimura, K; Kurokawa, H; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
| Aboul-ela, F; Allam, K; Bodoor, K; Boisdore, M; Boyapati, V; Gopu, V; Miller, J; Treleaven, WD; Weldeghiorghis, T | 1 |
| Laev, SS; Lavrik, OI; Salakhutdinov, NF | 1 |
| Gomez-Lus, R; Vergara, Y | 1 |
| Ellington, AD; Lato, SM | 1 |
| Chen, Q; Kuntz, ID; Shafer, RH | 1 |
| Bedwell, DM; Keeling, K; Manuvakhova, M | 1 |
| Blanchard, JS; Brewer, CF; Dam, TK; Hegde, SS | 1 |
| Barbieri, CM; Kaul, M; Kerrigan, JE; Pilch, DS | 2 |
| Hamano, Y; Hoshino, Y; Nakamori, S; Takagi, H | 1 |
| Aboul-ela, F; François, B; Masquida, B; Murray, JB; Russell, RJ; Vicens, Q; Westhof, E | 1 |
| Jobson, A; Liao, Z; Pommier, Y; Thibaut, L | 1 |
| Bernacchi, S; Dumas, P; Ennifar, E; Freisz, S; Maechling, C; Marquet, R; Spiess, B | 1 |
| Clausnitzer, D; Piepersberg, W; Wehmeier, UF | 1 |
| Da Veiga, C; Dumas, P; Ennifar, E; Mezher, J | 1 |
| Ennifar, E; Wolff, P | 1 |
| Baddal, B; Gülcan, HO; Teralı, K | 1 |
2 review(s) available for lividomycin and paromomycin
| Article | Year |
|---|---|
Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential.
Topics: Antigens, Neoplasm; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Humans; Phosphodiesterase Inhibitors; Poly-ADP-Ribose Binding Proteins; Structure-Activity Relationship | 2016 |
Thermodynamics of aminoglycoside-rRNA recognition.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Calorimetry; Computer Simulation; Databases as Topic; Electrolytes; Hydrogen Bonding; Hydrogen-Ion Concentration; Kinetics; Models, Chemical; Models, Molecular; Molecular Sequence Data; Neomycin; Nucleic Acid Conformation; Osmosis; Paromomycin; RNA; RNA, Ribosomal; Salts; Spectrophotometry; Temperature; Thermodynamics | 2003 |
20 other study(ies) available for lividomycin and paromomycin
| Article | Year |
|---|---|
Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
Topics: Aminoglycosides; Anti-Bacterial Agents; Biological Transport; Escherichia coli; Indicators and Reagents; Kinetics; Structure-Activity Relationship | 1987 |
Modeling RNA-ligand interactions: the Rev-binding element RNA-aminoglycoside complex.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antiviral Agents; Binding Sites; Computer Simulation; Crystallography, X-Ray; Gene Products, rev; Humans; Ligands; Macromolecular Substances; Models, Chemical; Models, Molecular; Nucleic Acid Conformation; Protein Conformation; Rhinovirus; RNA, Viral; Structure-Activity Relationship | 1998 |
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
Topics: Base Sequence; Binding Sites; Drug Design; Enzyme Inhibitors; Humans; Ligands; Nucleic Acid Conformation; Nucleic Acids; RNA; Telomerase; Telomere | 2004 |
Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Butirosin Sulfate; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Kanamycin; Kanamycin Kinase; Microbial Sensitivity Tests; Mutation; Neomycin; Stenotrophomonas maltophilia | 2007 |
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
Topics: Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Methyltransferases; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Plasmids; Protein Binding; Ribosome Subunits, Small; RNA, Ribosomal, 16S; Sequence Homology, Amino Acid | 2007 |
Design and implementation of an ribonucleic acid (RNA) directed fragment library.
Topics: Binding Sites; Chemistry, Physical; Databases, Factual; Drug Design; Ligands; Magnetic Resonance Spectroscopy; Molecular Weight; Organic Chemicals; Quality Control; RNA; Small Molecule Libraries | 2009 |
Aminoglycoside resistance in Haemophilus influenzae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Microbial; Drug Resistance, Multiple; Haemophilus influenzae; Kanamycin; Neomycin; Paromomycin; Phosphotransferases (Alcohol Group Acceptor); Streptomycin | 1995 |
Screening chemical libraries for nucleic-acid-binding drugs by in vitro selection: a test case with lividomycin.
Topics: Animals; Base Sequence; Binding Sites; Chickens; Chromatography, Affinity; Drug Evaluation, Preclinical; Gene Library; Goats; Humans; Mice; Molecular Sequence Data; Nucleic Acid Conformation; Paromomycin; RNA, Ribosomal; Sequence Homology, Nucleic Acid | 1996 |
Structure-based discovery of ligands targeted to the RNA double helix.
Topics: Aminoglycosides; Anti-Bacterial Agents; Circular Dichroism; Computer Simulation; Kanamycin; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Neomycin; Nucleic Acid Conformation; Nucleic Acid Denaturation; Paromomycin; Poly A-U; RNA, Double-Stranded; Software; Titrimetry | 1997 |
Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system.
Topics: Animals; Anti-Bacterial Agents; Cinnamates; Codon, Terminator; Dose-Response Relationship, Drug; Escherichia coli; Genes, Reporter; Gentamicins; Humans; Hygromycin B; Kanamycin; Neomycin; Paromomycin; Plasmids; Protein Biosynthesis; Rabbits; Reticulocytes; Ribosomes; RNA, Messenger; Sisomicin; Streptomycin; Tobramycin | 2000 |
Thermodynamics of aminoglycoside and acyl-coenzyme A binding to the Salmonella enterica AAC(6')-Iy aminoglycoside N-acetyltransferase.
Topics: Acetyltransferases; Acyl Coenzyme A; Anti-Bacterial Agents; Binding Sites; Calorimetry; Mutagenesis, Site-Directed; Paromomycin; Ribostamycin; Salmonella enterica; Spectrometry, Fluorescence; Thermodynamics; Tobramycin | 2002 |
Coupling of drug protonation to the specific binding of aminoglycosides to the A site of 16 S rRNA: elucidation of the number of drug amino groups involved and their identities.
Topics: Anti-Bacterial Agents; Binding Sites; Calorimetry, Differential Scanning; Carbohydrate Sequence; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Sequence Data; Neomycin; Paromomycin; Protons; RNA, Ribosomal, 16S | 2003 |
Overexpression and characterization of an aminoglycoside 6'-N-acetyltransferase with broad specificity from an epsilon-poly-L-lysine producer, Streptomyces albulus IFO14147.
Topics: Acetyltransferases; Amikacin; Amino Acid Sequence; Catalysis; Chromatography, Thin Layer; Cloning, Molecular; DNA; Electrophoresis, Polyacrylamide Gel; Enterococcus faecium; Escherichia coli; Hydrolysis; Kanamycin; Kinetics; Models, Chemical; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Paromomycin; Plasmids; Polylysine; Salmonella enteritidis; Sequence Homology, Amino Acid; Streptomyces; Substrate Specificity | 2004 |
Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding.
Topics: Adenine; Aminoglycosides; Anti-Bacterial Agents; Anticodon; Base Sequence; Binding Sites; Codon; Crystallography, X-Ray; Framycetin; Gentamicins; Kanamycin; Models, Molecular; Oligoribonucleotides; Paromomycin; Ribosomes; Ribostamycin; RNA, Ribosomal, 16S | 2005 |
Inhibition of human tyrosyl-DNA phosphodiesterase by aminoglycoside antibiotics and ribosome inhibitors.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; DNA Repair; DNA, Recombinant; DNA, Single-Stranded; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Kinetics; Molecular Structure; Neomycin; Nucleic Acid Heteroduplexes; Oligonucleotides; Paromomycin; Phosphoric Diester Hydrolases; Substrate Specificity; Time Factors | 2006 |
Aminoglycoside binding to the HIV-1 RNA dimerization initiation site: thermodynamics and effect on the kissing-loop to duplex conversion.
Topics: 5' Untranslated Regions; Aminoglycosides; Anti-Bacterial Agents; Antiviral Agents; Binding Sites; Calorimetry; Cinnamates; Dimerization; HIV-1; Hygromycin B; Models, Molecular; Nebramycin; Nucleic Acid Conformation; Paromomycin; RNA, Viral; Thermodynamics | 2007 |
The oxidoreductases LivQ and NeoQ are responsible for the different 6'-modifications in the aminoglycosides lividomycin and neomycin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Molecular Structure; Neomycin; Oxidoreductases; Paromomycin; Streptomyces; Substrate Specificity; Transaminases | 2011 |
Isothermal Titration Calorimetry: Assisted Crystallization of RNA-Ligand Complexes.
Topics: 5' Untranslated Regions; Aminoglycosides; Base Sequence; Calorimetry; Crystallization; Crystallography, X-Ray; DNA; Kinetics; Ligands; Molecular Sequence Data; Nucleic Acid Conformation; Paromomycin; Protein Binding; RNA; Software; Temperature; Thermodynamics | 2016 |
Native Electrospray Ionization Mass Spectrometry of RNA-Ligand Complexes.
Topics: Dimerization; HIV-1; Ligands; Nucleic Acid Conformation; Paromomycin; RNA, Viral; Spectrometry, Mass, Electrospray Ionization | 2020 |
Prioritizing potential ACE2 inhibitors in the COVID-19 pandemic: Insights from a molecular mechanics-assisted structure-based virtual screening experiment.
Topics: Amino Acid Motifs; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Carbazoles; Catalytic Domain; Coronavirus Infections; COVID-19; Drug Repositioning; Dyphylline; Host-Pathogen Interactions; Humans; Hydroxamic Acids; Ligands; Molecular Docking Simulation; Pandemics; Paromomycin; Pemetrexed; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protein Binding; Protein Interaction Domains and Motifs; Protein Structure, Secondary; SARS-CoV-2; Small Molecule Libraries; Structure-Activity Relationship; Thermodynamics | 2020 |